EUVIMEDEUVIMED entdecken
Open Access

Synthesis, Anticancer Evaluation, and Molecular Docking of Triazolylmethyl‐Dihydroquinazolinyl Benzoate Derivatives as Potential PARP‐1 Inhibitors

Shyam V Londhe, Pornima N Gund, Shriram B Pawar, Somesh S Salunke, Somdatta Chaudhari, Anita V Malusare, Prafulla B Choudhari, Kishan P Haval iD

Chemistry & Biodiversity · 2026-01 · 23 (1)

DOI: 10.1002/cbdv.202503325 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 08.01.2026. Verfasst von Shyam V Londhe und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Dr. Babasaheb Ambedkar Marathwada University SubCampus, Dharashiv, India. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Antineoplastic Agents, Poly (ADP-Ribose) Polymerase-1, Triazoles. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Quinazolinone derivatives have emerged as promising scaffolds in medicinal chemistry due to their broad spectrum of biological activities, including anticancer potential. Incorporation of triazole rings through click chemistry has further boosted the pharmacological relevance of such compounds, due to the triazole's stability, bioisosterism, and ability to engage in key interactions with biological targets. Motivated by these properties, a library of 24 triazolylmethyl‐dihydroquinazolinyl benzoate (TDB) derivatives ( 7a – x ) was synthesized using a click chemistry strategy, starting from anthranilamide and phthalic anhydride. The structures of the synthesized compounds were established through IR, 1 H NMR, 13 C NMR, and HRMS spectral analysis. The anticancer potential of all derivatives was evaluated by using SRB assay, with compounds 7j and 7q displaying notable activity, with GI 50 values of 22 and 48 µg/mL, respectively. In addition, compounds 7a , 7e , 7f , 7l , 7u , 7v , and 7x displayed moderate activity, with GI 50 values ranging from 58 to 77 µg/mL. In addition, molecular docking studies were performed using poly(ADP‐ribose) polymerase‐1 as the target enzyme, and the results confirmed that the TDB derivatives exhibited strong binding affinity. Furthermore, molecular dynamics simulations were conducted to evaluate the stability of the docked complexes, specifically for compounds 7j and 7q , which confirmed that the TDB derivatives formed stable interactions with poly(ADP‐ribose) polymerase‐1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Molecular Docking SimulationAntineoplastic AgentsPoly (ADP-Ribose) Polymerase-1TriazolesPoly(ADP-ribose) Polymerase InhibitorsBenzoatesQuinazolinonesStructure-Activity RelationshipHumansDrug Screening Assays, AntitumorMolecular StructureCell ProliferationCell Line, TumorDose-Response Relationship, Drug

Stichwörter der Autor:innen

1,2,3‐triazoleDFT studyanticancermolecular dockingquinazolinone

Substanzen

Antineoplastic AgentsPoly (ADP-Ribose) Polymerase-1TriazolesPoly(ADP-ribose) Polymerase InhibitorsBenzoatesPARP1 protein, humanQuinazolinones

Autor:innen und Institutionen

  • Department of Chemistry, Dr. Babasaheb Ambedkar Marathwada University SubCampus, Dharashiv, India.
  • Department of Pharmaceutical Chemistry, PES Modern College of Pharmacy, Pune, India.
  • Department of Pharmaceutical Chemistry, Bharati Vidyapeeth College of Pharmacy, Kolhapur, India.

ORCID-Profile: Kishan P Haval

Zitieren

APA

Londhe, S. V., Gund, P. N., Pawar, S. B., Salunke, S. S., Chaudhari, S., Malusare, A. V., Choudhari, P. B., & Haval, K. P. (2026). Synthesis, Anticancer Evaluation, and Molecular Docking of Triazolylmethyl‐Dihydroquinazolinyl Benzoate Derivatives as Potential PARP‐1 Inhibitors. Chemistry & Biodiversity, 23(1). https://doi.org/10.1002/cbdv.202503325

Vancouver

Londhe SV, Gund PN, Pawar SB, Salunke SS, Chaudhari S, Malusare AV, et al. Synthesis, Anticancer Evaluation, and Molecular Docking of Triazolylmethyl‐Dihydroquinazolinyl Benzoate Derivatives as Potential PARP‐1 Inhibitors. Chemistry & Biodiversity. 2026;23(1). doi:10.1002/cbdv.202503325

BibTeX
@article{Londhe2026,
  author = {Londhe, Shyam V and Gund, Pornima N and Pawar, Shriram B and Salunke, Somesh S and Chaudhari, Somdatta and Malusare, Anita V and Choudhari, Prafulla B and Haval, Kishan P},
  title = {Synthesis, Anticancer Evaluation, and Molecular Docking of Triazolylmethyl‐Dihydroquinazolinyl Benzoate Derivatives as Potential PARP‐1 Inhibitors},
  journal = {Chemistry & Biodiversity},
  year = {2026},
  volume = {23},
  number = {1},
  doi = {10.1002/cbdv.202503325}
}
Kostenlos starten →